West Pharmaceutical Services, Inc. (NYSE: WST)today announced that Jeffrey McGuire, Ph.D., has joined the company as Vice President of Business Development, Drug Delivery Division, North America.
In this new role, Dr. McGuire will be responsible for establishing collaborations and licenses with North American pharmaceutical and biotechnology companies for West’s Drug Delivery Division. Prior to joining West, Dr. McGuire was the Senior Vice President of Scientific Affairs for Enzon, Incorporated. He also served as Vice President for Research & Development and Chief Scientific Officer, and as Director of Business Development at Enzon.
“We were fortunate to get someone with Jeff’s expertise to join our efforts in positioning West as a leading drug delivery company”, said Bruce S. Morra, Ph.D., President of West’s Drug Delivery Systems Division. “Jeff will focus on finding appropriate partners to commercialize the innovative nasally and orally delivered products currently being developed at West, as well as identify opportunities where West’s unique skills can add significant value to both conventional and biotech drugs of interest to our clients.”
Dr. McGuire earned a Ph.D. in Life Sciences from the University of Delaware and a B.S. in Biological Science from the Massachusetts Institute of Technology. He also completed postdoctoral research at Harvard Medical School.
